The appendicitis treatment market has seen considerable growth due to a variety of factors.
• The appendicitis treatment market has grown significantly in recent years. It is expected to increase from $4.1 billion in 2024 to $4.39 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.1%.
This growth is driven by the rising incidence of pediatric appendicitis, the widespread use of antibiotics in treatment, the aging population, sedentary lifestyles, and favorable reimbursement policies.
The appendicitis treatment market is expected to maintain its strong growth trajectory in upcoming years.
• The appendicitis treatment market is projected to grow, reaching $5.72 billion by 2029 with a CAGR of 6.8%.
The growth is driven by a focus on early diagnosis, increased research activities, rising obesity rates, availability of effective medications, and a growing number of ambulatory surgical centers. Trends include advancements in minimally invasive surgery, improved diagnostic imaging, AI integration in decision support, new antibiotic development, and innovations in surgical stapling.
The rise in lifestyle-related health issues is anticipated to drive the growth of the appendicitis treatment market. These conditions are linked to sedentary lifestyles, poor diets, and high stress levels, which can affect gut health and increase inflammation. For instance, in March 2024, the World Health Organization reported that 1 in 8 people globally were affected by obesity, with 2.5 billion overweight adults and 37 million children under 5 also being affected in 2022. This growing prevalence of lifestyle-related diseases is expected to propel the appendicitis treatment market.
The appendicitis treatment market covered in this report is segmented –
1) By Type: Acute Appendicitis, Chronic Appendicitis
2) By Treatment: Surgery, Laparoscopic Surgery, Open Laparotomy, Medication, Other Treatments
3) By Route Of Administration: Oral, Parenteral
4) By End Users: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End Users
Subsegments:
1) By Acute Appendicitis: Surgical Treatment (Appendectomy), Non-Surgical Treatment (Antibiotics and Observation)
2) By Chronic Appendicitis: Surgical Treatment (Appendectomy), Medical Management (Antibiotics, Pain Management)
Companies operating in the appendicitis treatment market are integrating advanced technologies, such as AI-powered live stream surgical technology, to enhance surgical precision and improve patient outcomes. AI-integrated live-stream surgical technology uses artificial intelligence to optimize surgical procedures by providing real-time video streaming and detailed insights. In April 2024, Medtronic plc, an Ireland-based medical device company, introduced AI-driven algorithms and live-streaming technology to enhance their touch surgery performance insights platform. This innovation improves the quality of appendicitis treatment by optimizing surgical techniques, providing valuable training for surgeons, and increasing access to expert guidance.
Major companies operating in the appendicitis treatment market are:
• Pfizer Inc.
• Johnson & Johnson
• Roche Holding AG
• Merck & Co Inc
• AbbVie Inc.
• Sanofi Inc.
• AstraZeneca Inc
• Novartis AG
• Medtronic Plc
• Eli Lilly and Company
• Stryker Corporation
• Teva Pharmaceutical Industries Ltd
• Baxter International Inc
• Boston Scientific Corporation
• B. Braun Melsungen
• Olympus Corporation
• Smith & Nephew Plc
• Perrigo Company
• Cipla Inc.
• Cook Medical
• Integra LifeSciences
• Teligent Inc.
North America was the largest region in the appendicitis treatment market in 2024. The regions covered in the appendicitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.